Top Pilot R&D and Production Platform

 

biomedical r&d and Production Platform

Having the ability of development of small scale processes and pilot production. The expression of Fed-Batch culture reaches the international leading level.

 

Having cardiovascular drug discovery platforms of affinity chromatography, ion exchange chromatography, composite mode chromatography, nano filtration and other purification chromatography technologies. Having capacity of fine purification of target antibodies and production of high purity protein stock solution.

 

Having a mature preparation filling platform, which produces different specifications of drug products such as pre-filled syringes, vials, and cilin bottles, and the filling accuracy exceeds the industry average level.

 

For more information about antibody development and drug discovery industry, please feel free to contact us!

 

There are many bispecific antibody companies, but we are one of the best choices for you.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Sungen Biomedical was founded in 2019 which is an innovative antibody drug research and development enterprise incubated by Hotgen Biotech (SH688068), a listed company on the Sci-Tech innovation board. The co-founder of Sungen Biomedical is Professor Zhiwei Sun, Vice Chairman of China Monoclonal Antibody Industry Committee. https://www.etowertech.com/